Web Results

Sunitinib - Wikipedia


Sunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell ...

RCC | GIST | PNET | SUTENT® (sunitinib malate) Safety Info ...


SUTENT® (sunitinib malate) for treatment of advanced renal cell carcinoma, gastrointestinal stromal tumors & advanced pancreatic NET. Risk info for SUTENT®.

Sunitinib - Chemotherapy Drugs - Chemocare


Trade Name: Sutent <sup>®</sup> Other Name: SU11248. Drug Type: Sunitinib is a targeted therapy and is a receptor protein-tyrosine kinase inhibitor. It inhibits the actions ...

Definition of sunitinib malate - NCI Drug Dictionary - National ...


Sunitinib blocks the tyrosine kinase activities of vascular endothelial growth factor receptor 2 (VEGFR2), platelet-derived growth factor receptor b (PDGFRb), and ...

Sunitinib | C22H27FN4O2 - PubChem


Sunitinib is an indolinone derivative and tyrosine kinase inhibitor with potential antineoplastic activity. Sunitinib blocks the tyrosine kinase activities of vascular ...

DrugBank: Sunitinib


May 16, 2007 ... Sunitinib is metabolized primarily by the cytochrome P450 enzyme, CYP3A4, to produce its primary active metabolite, which is further ...

Sunitinib: Indications, Side Effects, Warnings - Drugs.com


Easy to read patient leaflet for sunitinib. Includes indications, proper use, special instructions, precautions, and possible side effects.

Sunitinib (Sutent®) | OncoLink


Jan 13, 2016 ... Sunitinib (Sutent®) is an oral multikinase inhibitor used in the treatment of some types of gastrointestinal stromal tumors, renal cell cancers and ...

Sunitinib (Sutent®) - Cancer information - Macmillan Cancer Support


Find out more about sunitinib (also called Sutent®), which may be used to treat a type of kidney cancer called renal cell carcinoma (RCC), gastrointestinal ...

Sutent (Sunitinib Malate): Side Effects, Interactions, Warning ... - RxList


Mar 10, 2015 ... SUTENT, an oral multi-kinase inhibitor, is the malate salt of sunitinib. Sunitinib malate is described chemically as Butanedioic acid, hydroxy-, ...

More Info

Sunitinib: MedlinePlus Drug Information


Aug 15, 2016 ... Sunitinib may cause serious or life-threatening damage to the liver. Tell your doctor if you have or have ever had liver disease or problems with ...

Sunitinib (Sutent) | Cancer Research UK


May 12, 2015 ... Read about the cancer treatment drug sunitinib, otherwise known as Sutent, including what it is, how it works and possible side effects.

Sunitinib Malate - National Cancer Institute


Oct 5, 2006 ... This page contains brief information about sunitinib malate and a collection of links to more information about the use of this drug, research ...